Intercept: 4Q Earnings Snapshot
NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Tuesday reported a loss of $98.2 million in its fourth quarter.
The New York-based company said it had a loss of $2.99 per share.
The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.56 per share.
The drugmaker posted revenue of $71.5 million in the period, which beat Street forecasts. Nine analysts surveyed by Zacks expected $68.5 million.
For the year, the company reported that its loss widened to $344.7 million, or $10.89 per share. Revenue was reported as $252 million.
Intercept shares have dropped 27% since the beginning of the year. The stock has declined almost 3% in the last 12 months.